BAX Company Profile and Key Details

Q: Who are the executives of BAX?

Mr. Cristiano FranziInterim Head of Kidney Care Global Bus. Unit, Senior Vice President & Pres for EMEAMs. Jacqueline Kunzler Ph.D.?Senior Vice President & Chief Quality OfficerMr. Brian C. StevensSenior Vice President, Interim Chief Financial Officer, Chief Accounting Officer & ControllerMr. James W. BorziSenior Vice President & Chief Supply Chain OfficerMs. Jeanne K. MasonSenior Vice President of HRMs. Stacey EisenSenior Vice President of Global CommunicationsMr. David S. RosenbloomExecutive Vice President & Gen. CounselMr. Jose E. AlmeidaChairman, Pres & Chief Executive OfficerMr. Giuseppe AccogliExecutive Vice President & Chief Operating OfficerMr. Talvis P. LoveSenior Vice President & Chief Information OfficerMs. Clare TrachtmanVice President of Investor RelationsMr. Andrew FryePres of Patient Support Systems, Global Surgical Solutions & Enterprise ConnectivityMs. Jeanne K. Mason Ph.D.?Senior Vice President & Chief HR OfficerMr. James K. SaccaroVice President & Chief Financial Officer

NYSE : BAX

Baxter International

$18.96

-0.11-0.58%

At Close 4:00 PM

73.82

B+ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Baxter International Inc. (BAX) stock surged +0.11%, trading at $18.98 on NYSE, up from the previous close of $18.96. The stock opened at $18.85, fluctuating between $18.85 and $19.22 in the recent session.

Stock Snapshot

18.96

Prev. Close

9.76B

Market Cap

18.85

Day Low

-27.11

P/E Ratio

-0.7

EPS (TTM)

2.04

Cash Flow per Share

18.85

Open

514M

Number of Shares

19.22

Day High

99.58%

Free Float in %

16.57

Book Value

6.92M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Dec 19, 2025	19.06	19.31	18.94	18.96	15.44M
Dec 17, 2025	19.00	19.41	18.97	19.29	8.13M
Dec 16, 2025	19.54	19.57	18.82	19.05	8.68M
Dec 15, 2025	19.25	19.82	19.12	19.53	9.14M
Dec 12, 2025	19.00	19.34	18.92	19.15	10.79M
Dec 11, 2025	18.38	18.91	18.25	18.90	8.94M
Dec 10, 2025	18.20	18.39	17.92	18.26	11.59M
Dec 09, 2025	18.10	18.30	18.01	18.16	6.33M
Dec 08, 2025	18.65	18.68	18.11	18.16	9.19M
Dec 05, 2025	18.64	18.81	18.46	18.54	8.56M
Dec 04, 2025	18.84	18.93	18.33	18.48	7.91M
Dec 03, 2025	19.00	19.17	18.86	18.89	6.09M
Dec 02, 2025	18.99	18.99	18.59	18.84	7.13M
Dec 01, 2025	18.62	19.20	18.54	19.08	9.63M
Nov 28, 2025	18.72	18.84	18.61	18.74	3.77M
Nov 26, 2025	18.59	18.95	18.53	18.91	7.16M
Nov 25, 2025	18.34	18.72	18.20	18.66	4.97M
Nov 24, 2025	18.31	18.46	18.11	18.18	8.38M
Nov 21, 2025	17.58	18.61	17.56	18.31	8.27M
Nov 20, 2025	17.66	17.86	17.40	17.42	8.3M

Contact Details

Deerfield, IL 60015

United States

https://www.baxter.com 224 948 2000

About Company

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Stock Peers

WST

3.88+1.44%

West Pharmaceutical Services, Inc.$272.54 RMD

2.39+0.99%

ResMed Inc.$244.94 BDX

0.89+0.46%

Becton, Dickinson and Company$195.59 TFX

-2.61-2.10%

Teleflex Incorporated$121.89 ATR

-1.23-1.00%

AptarGroup, Inc.$121.39 HAE

0.31+0.39%

Haemonetics Corporation$80.21 ALC

0.475+0.60%

Alcon Inc.$79.97 WRBY

-0.34-1.27%

Warby Parker Inc.$26.39 STVN

0.01+0.05%

Stevanato Group S.p.A.$20.53 BLCO

0.08+0.47%

Bausch + Lomb Corporation$16.98

Company Overview

Baxter International Inc. (NYSE:BAX) closed at $18.98 USD, gaining $0.02 (0.11%) from the previous close of $18.96. The stock is currently mid-range between its 52-week high and low $17.40 and $37.74. With a market capitalization of about $9.76 billion, Baxter International Inc. is classified as a mid-cap and shows lower-than-market volatility (beta ~0.61). Key stats such as the average daily volume over the past year has been around 7.93 million shares, in line with its 52-week average. Headquartered in Deerfield, IL, Baxter International Inc. operates in the Healthcare sector and the Medical - Instruments & Supplies industry. Led by CEO Andrew Hider, the company employs approximately 38,000 people and listed since October 27, 1981. Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide.

Technical Performance

BAX has shown mixed momentum, gaining 0.32% over the past week and -17.64% over the past quarter, though year-to-date performance is down -34.98%. Short-term trend indicators are bullishly aligned (SMA20 1.08%, SMA50 -3.73%, SMA200 -27.55%). The stock’s 14-day RSI is 49.32 (neutral), while the ATR of 0.54 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -49.76% below its high and over 8.97% above its low. Average 10-day trading volume of 10.44 million shares is slightly above the 3-month average of 7.75 million, indicating heightened recent market interest.

Valuation Metrics

Baxter International Inc. trades at a P/E ratio of -28.51, slightly below the S&P 500 average, with a price-to-sales ratio of 0.88 and a price-to-book ratio of 1.34 suggesting the stock is closer to book value. The P/FCF stands at -441.92, also above market averages.

Dividend & Fair Value

Baxter International Inc. last paid a dividend of 0.52 per share, this equals a trailing yield of roughly 3.06%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $36.65. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Wall Street analysts project EPS growth of 9.3% annually over the next five years. The latest quarter delivered EPS of -$0.09. The next quarter is forecast at $0.54. Next year's EPS is expected at $15.80. Analyst sentiment is neutral. Analyst rating data shows there are 5 Strong Buy ratings, 1 Buy ratings, 8 Hold ratings, 0 Sell rating and 2 Strong Sell ratings. Price targets range from $42.00 to $19.00. The high target offers 121.52% upside. The low target suggests 0.21% downside. The mean target is $30.12. This offers 58.86% upside. Baxter International Inc. earnings surprise history is a mixed track record. The quarter that ended October 30, 2025, missed forecasts by -114.91%. The prior quarter beat by -1.67%. Over the last six quarters, Apple has recorded several small beats. These include 3.03% in August 06, 2024.

Shareholding & Insider Activity

Baxter International Inc. has 513.62 million shares outstanding. The public float is 511.46 million shares, elevated short interest at 7.98% of float. This equals 27.23 million shares. The short ratio is 4.06 days. Institutional investors hold 102.74% of the float. Insiders own 0.37%. Third Point LLC holds 23.01 million shares, Mason Jeanne K has 142.29 thousand shares and Accogli Giuseppe has 66.52 thousand shares.

Financial & Profitability Overview

Over the trailing twelve months, Baxter International generated $14.81B in revenue, or $29.27 per share. Gross margin was 33.59%, operating margin 2.63%, and net profit margin 17.93%. Returns are healthy, with ROA at 9.39% and ROE at 31.61%.
On valuation metrics, Baxter International trades at a P/E of -28.51, P/S of 0.88 and P/B of 1.34. The current ratio is 1.84 and quick ratio is 1.18. Operationally, the company’s inventory turnover is 2.90 and cash conversion cycle is 136.07 days. Debt-to-equity is 1.34, supported by a cash flow-to-debt ratio of 0.05.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Baxter International posted revenue of $14.81B, down slightly from $15.11B in the prior quarter. Gross profit was $4.98B (margin 33.59%). Operating income was $390.00M (margin 2.6%). Net income was$2.66B (EPS - $0.45).
The company ended the quarter with $3.20B in cash and short-term investments, a total debt of $14.36B, and net debt of $11.17B. Total assets were $28.28B, with equity of $8.47B. Financials further reflected stability, with operating cash flow of $1.73B, free cash flow of $1.03B, and capital expenditures of - $692.00M.

Price Forecast & Outlook

Our AI price prediction model suggests that Baxter International Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 2.32%, with price expected at $19.40 by January 02, 2026, within a range of $18.89 to $19.91 3-Month Outlook: Projected rise of 6.38%, reaching $20.17 by March 19, 2026, with a range of $19.53 to $20.91. 1-Year Outlook: Projected loss of -52.06%, with price at $9.09 by December 18, 2026, within a range of $7.69 to $10.56.

Key Takeaways

Baxter International Inc. (NYSE:BAX) shares are down -34.98% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Baxter International Inc. trading at a premium to the broader market with a P/E of -28.51. Analyst sentiment is cautious, with the majority of ratings in Underweight territory and a mean price target of $53.85, suggesting 184.02% upside. Our AI forecast model points to short-term strength (2.32% over two weeks), a medium-term rise (6.38% over three months), and a longer-term loss (-52.06% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Baxter International Inc. (BAX) stock price?

Baxter International Inc. (NYSE: BAX) stock price is $18.98 in the last trading session. During the trading session, BAX stock reached the peak price of $19.22 while $18.85 was the lowest point it dropped to. The percentage change in BAX stock occurred in the recent session was 0.11% while the dollar amount for the price change in BAX stock was $0.02.

BAX's industry and sector of operation?

The NYSE listed BAX is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector. Baxter International Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of BAX?

Mr. Cristiano Franzi
Interim Head of Kidney Care Global Bus. Unit, Senior Vice President & Pres for EMEA
Ms. Jacqueline Kunzler Ph.D.
?Senior Vice President & Chief Quality Officer
Mr. Brian C. Stevens
Senior Vice President, Interim Chief Financial Officer, Chief Accounting Officer & Controller
Mr. James W. Borzi
Senior Vice President & Chief Supply Chain Officer
Ms. Jeanne K. Mason
Senior Vice President of HR
Ms. Stacey Eisen
Senior Vice President of Global Communications
Mr. David S. Rosenbloom
Executive Vice President & Gen. Counsel
Mr. Jose E. Almeida
Chairman, Pres & Chief Executive Officer
Mr. Giuseppe Accogli
Executive Vice President & Chief Operating Officer
Mr. Talvis P. Love
Senior Vice President & Chief Information Officer
Ms. Clare Trachtman
Vice President of Investor Relations
Mr. Andrew Frye
Pres of Patient Support Systems, Global Surgical Solutions & Enterprise Connectivity
Ms. Jeanne K. Mason Ph.D.
?Senior Vice President & Chief HR Officer
Mr. James K. Saccaro
Vice President & Chief Financial Officer

How BAX did perform over past 52-week?

BAX's closing price is 8.97% higher than its 52-week low of $17.40 where as its distance from 52-week high of $37.74 is -49.76%.

How many employees does BAX have?

Number of BAX employees currently stands at 38,000.

Link for BAX official website?

Official Website of BAX is: https://www.baxter.com

How do I contact BAX?

BAX could be contacted at phone 224 948 2000 and can also be accessed through its website. BAX operates from One Baxter Parkway, Deerfield, IL 60015, United States.

How many shares of BAX are traded daily?

BAX stock volume for the day was 6.92M shares. The average number of BAX shares traded daily for last 3 months was 7.93M.

What is the market cap of BAX currently?

The market value of BAX currently stands at $9.76B with its latest stock price at $18.98 and 514M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	38000
Beta	0.61
Sales or Revenue	$14.81B
5Y Sales Change%	-0.015%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Instruments & Supplies

BAX Company Profile and Key Details

Baxter International

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Company Overview

Shareholding & Insider Activity

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Key Takeaways

Price Forecast & Outlook

Valuation Metrics